Gain Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €25.42M +∞% -€8.79M -66.7% -34.6% -0.35 pp N/A N/A
    (estimated) €0.00 +NaN% -€26.41M +12.8% N/A N/A N/A
    (estimated) €0.00 -100.0% -€23.42M -2.6% N/A N/A N/A
    (estimated) €42.92K +∞% -€24.05M +36.5% -56,040.0% -560 pp N/A N/A
    (estimated) €0.00 +NaN% -€17.62M +0.6% N/A N/A N/A
    €0.00 -100.0% -€17.52M -8.3% N/A -€16.18M +0.0% N/A
    €47.37K -60.6% -€19.12M +26.6% -40,354.3% -280 pp -€16.18M +29.4% -34,161.9% -240 pp
    €120.27K -15.1% -€15.10M +26.6% -12,555.1% -41 pp -€12.51M +18.8% -10,401.4% -30 pp
    €141.64K +471.3% -€11.92M +288.3% -8,418.9% +40 pp -€10.53M +281.2% -7,437.5% +37 pp
    €24.79K -30.1% -€3.07M +63.1% -12,387.7% -71 pp -€2.76M +73.6% -11,147.2% -67 pp
    €35.45K +100.4% -€1.88M +98.4% -5,310.9% +0.53 pp -€1.59M +151.8% -4,490.9% -9.2 pp
    €17.69K -€949.04K -5,364.4% -€632.27K -3,573.8%

    Notifications